Emphasis of FAS/FASL gene polymorphism in patients with non-muscle invasive bladder cancer
ConclusionEvaluation ofFAS/FASL polymorphisms can predict lack of response to BCG immunotherapy and prevent the loss of valuable time before such alternative treatments as early cystectomy are initiated.
Source: Irish Journal of Medical Science - Category: General Medicine Source Type: research
More News: Biomedical Science | Bladder Cancer | Cancer | Cancer & Oncology | General Medicine | Genetics | Immunotherapy | Ireland Health | Science | Study